Depression Signposts

1,618 views · Published 20 April 2016 · 17:44 · Indexed 31 October 2026

Channel: TVO Today · 2016 · Education

Watch on YouTube

The Canadian Biomarker Integration Network for Depression, known as CAN-BIND, is a cross-country study searching for biological and clinical characteristics that will help guide treatment for depression. Heading it up is Harriet Feilotter, director of molecular diagnostics at Queen's University. She joins The Agenda to discuss the hope that a simple blood test will be able to identify who responds well to particular drugs to treat depression.

More from this channel